Roman Iakoubov

987 total citations
14 papers, 588 citations indexed

About

Roman Iakoubov is a scholar working on Endocrinology, Diabetes and Metabolism, Infectious Diseases and Surgery. According to data from OpenAlex, Roman Iakoubov has authored 14 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Infectious Diseases and 4 papers in Surgery. Recurrent topics in Roman Iakoubov's work include Diabetes Treatment and Management (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Pancreatic function and diabetes (3 papers). Roman Iakoubov is often cited by papers focused on Diabetes Treatment and Management (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Pancreatic function and diabetes (3 papers). Roman Iakoubov collaborates with scholars based in Germany, Canada and United Kingdom. Roman Iakoubov's co-authors include Patricia L. Brubaker, Lina M. Lauffer, Catharine Whiteside, Angelo A. Izzo, Richard P. Bazinet, Ausma Ahmed, Anthony J. Grieco, Markus Thaler, Andreas Bietenbeck and Peter B. Luppa and has published in prestigious journals such as Diabetes, Endocrinology and Clinical Endocrinology.

In The Last Decade

Roman Iakoubov

14 papers receiving 575 citations

Peers

Roman Iakoubov

EDM

SURGE

PHYSI

J Schirra Germany

Leslie Glass United Kingdom

J.F. Gautier France

Anne K. McGavigan United Kingdom

John Myhre Denmark

Emanuele Filice Italy

Nicholas Bowker United Kingdom

Johannes Tschöp United States

Joerg Schirra Germany

Shiran Udi Israel

J Schirra Germany

Roman Iakoubov

407 ×1.3

EDM

267 ×1.1

SURGE

104 ×0.7

189 ×1.5

PHYSI

100 ×0.8

Citations per year, relative to Roman Iakoubov Roman Iakoubov (= 1×) peers J Schirra

Countries citing papers authored by Roman Iakoubov

Since Specialization

Citations

This map shows the geographic impact of Roman Iakoubov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roman Iakoubov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roman Iakoubov more than expected).

Fields of papers citing papers by Roman Iakoubov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roman Iakoubov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roman Iakoubov. The network helps show where Roman Iakoubov may publish in the future.

Co-authorship network of co-authors of Roman Iakoubov

This figure shows the co-authorship network connecting the top 25 collaborators of Roman Iakoubov. A scholar is included among the top collaborators of Roman Iakoubov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roman Iakoubov. Roman Iakoubov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Schneider, Jochen, Christoph D. Spinner, Roman Iakoubov, et al.. (2024). Clinical and immunological outcomes of SARS-CoV-2-infected vaccine responders, vaccine non-responders, and unvaccinated patients evaluated for neutralizing monoclonal antibody treatment at a single German tertiary care center: a retrospective cohort study with prospective follow-up. Infection. 52(3). 1143–1151. 3 indexed citations

Koehler, Friedrich, Peter Bramlage, Eik Vettorazzi, et al.. (2024). Impact of telemedical management on hospitalization and mortality in heart failure patients with diabetes: a post-hoc subgroup analysis of the TIM-HF2 trial. Cardiovascular Diabetology. 23(1). 198–198. 5 indexed citations

Gebhardt, Friedemann, Chlodwig Kirchhoff, Jens Gempt, et al.. (2021). Use of monoclonal antibody therapy for nosocomial SARS-CoV-2 infection in patients at high risk for severe COVID-19: experience from a tertiary-care hospital in Germany. Infection. 49(6). 1313–1318. 8 indexed citations

Würstle, Silvia, Christoph D. Spinner, Florian Voit, et al.. (2021). Self-sampling versus health care professional-guided swab collection for SARS-CoV-2 testing. Infection. 49(5). 927–934. 15 indexed citations

Spinner, Christoph D., Sebastian Schulz, Ulrike Bauer, et al.. (2017). Effects of antiretroviral combination therapies F/TAF, E/C/F/TAF and R/F/TAF on insulin resistance in healthy volunteers: The TAF-IR Study. Antiviral Therapy. 23(7). 629–632. 4 indexed citations

Noé, Sebastian, Alexander von Werder, Roman Iakoubov, et al.. (2016). Dynamics of Adrenocorticotropin after Application of Metyrapone. Experimental and Clinical Endocrinology & Diabetes. 125(1). 53–56. 3 indexed citations

Thaler, Markus, Roman Iakoubov, Andreas Bietenbeck, & Peter B. Luppa. (2015). Clinically relevant lot-to-lot reagent difference in a commercial immunoturbidimetric assay for glycated hemoglobin A1c. Clinical Biochemistry. 48(16-17). 1167–1170. 15 indexed citations

Spinner, Christoph D., Alexander Zink, Eva Wolf, et al.. (2015). Neither Boosted Elvitegravir nor Darunavir with Emtricitabine/Tenofovir Disoproxil Fumarate Increase Insulin Resistance in Healthy Volunteers: Results from the STRIBILD-IR Study. Antiviral Therapy. 21(7). 627–631. 9 indexed citations

Kühnen, Peter, Ved Bhushan Arya, Kathrin Hauptmann, et al.. (2014). Occurrence of giant focal forms of congenital hyperinsulinism with incorrect visualization by ¹⁸F DOPA‐PET/CT scanning. Clinical Endocrinology. 81(6). 847–854. 13 indexed citations

10.

Iakoubov, Roman, Ausma Ahmed, Lina M. Lauffer, Richard P. Bazinet, & Patricia L. Brubaker. (2011). Essential Role for Protein Kinase Cζ in Oleic Acid-Induced Glucagon-Like Peptide-1 Secretion in Vivo in the Rat. Endocrinology. 152(4). 1244–1252. 40 indexed citations

11.

Lauffer, Lina M., et al.. (2011). Novel Biological Action of the Dipeptidylpeptidase-IV Inhibitor, Sitagliptin, as a Glucagon-Like Peptide-1 Secretagogue. Endocrinology. 153(2). 564–573. 39 indexed citations

12.

Lauffer, Lina M., Roman Iakoubov, & Patricia L. Brubaker. (2009). GPR119 Is Essential for Oleoylethanolamide-Induced Glucagon-Like Peptide-1 Secretion From the Intestinal Enteroendocrine L-Cell. Diabetes. 58(5). 1058–1066. 307 indexed citations

13.

Iakoubov, Roman, et al.. (2009). Carcinogenic Effects of Exogenous and Endogenous Glucagon-Like Peptide-2 in Azoxymethane-Treated Mice. Endocrinology. 150(9). 4033–4043. 50 indexed citations

14.

Iakoubov, Roman, et al.. (2006). Protein Kinase Cζ Is Required for Oleic Acid-Induced Secretion of Glucagon-Like Peptide-1 by Intestinal Endocrine L Cells. Endocrinology. 148(3). 1089–1098. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact